Jefferies Raises Price Target and Estimates on Amgen (AMGN), Citing AMG-145 (PCSK9 Inhibitor) Potential
Tweet Send to a Friend
Jefferies maintains a 'Buy' on Amgen (NASDAQ: AMGN) price target of $88.00 (from $78.00).
Analyst, Eun K. Yang, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Eun K. Yang, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
